THE WOODLANDS, Texas, Dec. 22, 2015 /PRNewswire/ -- CB&I (NYSE: CBI) today announced it has been awarded a contract by Hengli Petrochemical (Dalian) Refinery Co. Ltd. The project scope includes the license and engineering design of a grassroots propane and butane dehydrogenation unit to be built in Dalian, Liaoning Province, China.
The unit will use CB&I's CATOFIN® catalytic dehydrogenation technology and Clariant's tailor-made CATOFIN catalyst to process feedstock containing 300,000 metric tons per year of propane and 600,000 metric tons per year of isobutane for the joint production of propylene and isobutylene. The unit is the largest single-train dehydrogenation plant in the world.
"CB&I's CATOFIN technology provides our customers with proven reliability and the flexibility to co-process multiple feed compositions at world scale capacities," said Daniel McCarthy, President of CB&I's Technology operating group. "In addition to this award, CLG, CB&I's joint venture with Chevron, was awarded the ISODEWAXING® catalytic isomerization and ISOFINISHING® hydrofinishing processes for this project. This multi-technology award underscores CB&I's broad portfolio of technology solutions."
About CB&I
CB&I (NYSE:CBI) is the most complete energy infrastructure focused company in the world. With 125 years of experience and the expertise of approximately 54,000 employees, CB&I provides reliable solutions while maintaining a relentless focus on safety and an uncompromising standard of quality. For more information, visit www.cbi.com.
Important Information For Investors And Shareholders
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements regarding CB&I and represents our expectations and beliefs concerning future events. These forward-looking statements are intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties. When considering any statements that are predictive in nature, depend upon or refer to future events or conditions, or use or contain words, terms, phrases or expressions such as "achieve," "forecast," "plan," "propose," "strategy," "envision," "hope," "will," "continue," "potential," "expect," "believe," "anticipate," "project," "estimate," "predict," "intend," "should," "could," "may," "might" or similar forward-looking statements, we refer you to the cautionary statements concerning risk factors and "Forward-Looking Statements" described under "Risk Factors" in Item 1A of our Annual Report filed on Form 10-K filed with the SEC for the year ended December 31, 2014, and any updates to those risk factors or "Forward-Looking Statements" included in our subsequent Quarterly Reports on Form 10-Q filed with the SEC, which cautionary statements are incorporated herein by reference.
Logo - http://photos.prnewswire.com/prnh/20130430/DA04155LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cbi-announces-catofin-technology-award-for-hengli-300196088.html
SOURCE CB&I
